Use of lipoxin compounds for inhibiting of TNF-(alfa) initiated neutrophil response

Details for Australian Patent Application No. 2004222825 (hide)

International Classifications

Event Publications

11 November 2004 Complete Application Filed

25 November 2004 Application Open to Public Inspection

Published as AU-A-2004222825

2 March 2006 Amendment Made

The nature of the amendment is: Amend the name of the applicant from Brigham and Women's Hospital to The Brigham and Women's Hospital, Inc.

31 May 2007 Application Accepted

Published as AU-A-2004222825

27 September 2007 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.